NZ219609A - Assay methods for inhibin - Google Patents
Assay methods for inhibinInfo
- Publication number
- NZ219609A NZ219609A NZ219609A NZ21960987A NZ219609A NZ 219609 A NZ219609 A NZ 219609A NZ 219609 A NZ219609 A NZ 219609A NZ 21960987 A NZ21960987 A NZ 21960987A NZ 219609 A NZ219609 A NZ 219609A
- Authority
- NZ
- New Zealand
- Prior art keywords
- inhibin
- assay methods
- assay
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPH501986 | 1986-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ219609A true NZ219609A (en) | 1990-09-26 |
Family
ID=3771514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ219609A NZ219609A (en) | 1986-03-13 | 1987-03-13 | Assay methods for inhibin |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0260306A4 (en) |
JP (1) | JPS63503086A (en) |
AU (1) | AU599373B2 (en) |
CA (1) | CA1307736C (en) |
IL (1) | IL81889A0 (en) |
NZ (1) | NZ219609A (en) |
WO (1) | WO1987005702A1 (en) |
ZA (1) | ZA871844B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5942220A (en) * | 1990-03-16 | 1999-08-24 | Chiron Corporation | Inhibitor of cytokine activity and applications thereof |
GB9224965D0 (en) * | 1992-11-28 | 1993-01-20 | Kodak Ltd | Antenatal screening for chromosomal abnormalities |
GB9316369D0 (en) * | 1993-08-06 | 1993-09-22 | Surface Active Ltd | Diagnostic method |
GB9410345D0 (en) * | 1994-05-24 | 1994-07-13 | Univ Oxford Brookes | Method of genetic testing |
GB9606261D0 (en) * | 1996-03-25 | 1996-05-29 | Johnson & Johnson Clin Diag | Prenatal screening for fetal abnormalities |
GB9614615D0 (en) * | 1996-07-11 | 1996-09-04 | Isis Innovation | Diagnosis of pre-eclampsia |
US6620590B2 (en) | 1996-07-11 | 2003-09-16 | Isis Innovation Limited | Diagnosis of pre-eclampsia |
US6787311B1 (en) | 1999-02-25 | 2004-09-07 | Auckland Uniservices Limited | Diagnosis of premature ovarian failure |
JP4903036B2 (en) | 2003-01-06 | 2012-03-21 | アンジオケム・インコーポレーテッド | Aprotinin and analogs as carriers that cross the blood brain barrier |
CA2520711A1 (en) * | 2003-03-28 | 2004-10-07 | Prostate Diagnostics Pty. Ltd. | Diagnosis of advanced cancer |
ES2527634T3 (en) | 2005-02-18 | 2015-01-27 | Angiochem Inc. | Aprotinin polypeptides to transport a compound through the blood-brain barrier |
AU2006272405B2 (en) | 2005-07-15 | 2013-02-07 | Angiochem Inc. | Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
US9365634B2 (en) | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
AU2009304560A1 (en) | 2008-10-15 | 2010-04-22 | Angiochem Inc. | Conjugates of GLP-1 agonists and uses thereof |
AU2009322043A1 (en) | 2008-12-05 | 2011-07-07 | Angiochem Inc. | Conjugates of neurotensin or neurotensin analogs and uses thereof |
CA2747220A1 (en) | 2008-12-17 | 2010-06-24 | Richard Beliveau | Membrane type-1 matrix metalloprotein inhibitors and uses thereof |
ES2729261T3 (en) | 2009-04-20 | 2019-10-31 | Angiochem Inc | Ovarian cancer treatment using an anticancer agent conjugated to an Angiopep-2 analog |
CA2766537A1 (en) | 2009-07-02 | 2011-01-06 | Angiochem Inc. | Multimeric peptide conjugates and uses thereof |
CA2989400A1 (en) | 2015-06-15 | 2016-12-22 | Angiochem Inc. | Ang1005 for the treatment of leptomeningeal carcinomatosis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1341617C (en) * | 1984-06-08 | 2011-06-28 | Henry George Burger | Inhibin isolated from ovarian follicular fluid |
KR940004077B1 (en) * | 1985-04-18 | 1994-05-11 | 바이오테크놀로지 오스트레일리아 프로프라이어터리 리밋티드 | Recombinantinhbin |
US4624944A (en) * | 1985-06-14 | 1986-11-25 | The Regents Of The University Of California | Human seminal alpha-inhibins |
US4740587A (en) * | 1985-07-18 | 1988-04-26 | The Salk Institute For Biological Studies | Inhibin and method of purifying same |
NZ231899A (en) * | 1985-10-03 | 1991-07-26 | Genentech Inc | Human or porcine inhibin peptide compositions and dna encoding them |
-
1987
- 1987-03-13 JP JP62502014A patent/JPS63503086A/en active Pending
- 1987-03-13 WO PCT/AU1987/000070 patent/WO1987005702A1/en not_active Application Discontinuation
- 1987-03-13 IL IL81889A patent/IL81889A0/en unknown
- 1987-03-13 ZA ZA871844A patent/ZA871844B/en unknown
- 1987-03-13 NZ NZ219609A patent/NZ219609A/en unknown
- 1987-03-13 EP EP19870902027 patent/EP0260306A4/en not_active Withdrawn
- 1987-03-13 CA CA000531961A patent/CA1307736C/en not_active Expired - Lifetime
- 1987-03-13 AU AU72036/87A patent/AU599373B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
CA1307736C (en) | 1992-09-22 |
EP0260306A4 (en) | 1990-09-26 |
ZA871844B (en) | 1988-05-25 |
EP0260306A1 (en) | 1988-03-23 |
WO1987005702A1 (en) | 1987-09-24 |
AU7203687A (en) | 1987-10-09 |
JPS63503086A (en) | 1988-11-10 |
IL81889A0 (en) | 1987-10-20 |
AU599373B2 (en) | 1990-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2197322B (en) | Antibodies | |
GB8305197D0 (en) | Assay methods | |
NZ219609A (en) | Assay methods for inhibin | |
GB8705650D0 (en) | Assay technique | |
GB2197323B (en) | Antibodies | |
GB8623494D0 (en) | Assay technique | |
GB8913474D0 (en) | Assay method | |
GB8820052D0 (en) | Assay device & method | |
GB8919411D0 (en) | Assay method | |
GB8800292D0 (en) | Assay method | |
GB8628108D0 (en) | Riboflavin-linked assay | |
EP0248621A3 (en) | Reagent for immunoassay | |
GB8621495D0 (en) | Assay | |
GB8922909D0 (en) | Assay method | |
GB8710074D0 (en) | Antibodies | |
GB8624891D0 (en) | Assay method | |
GB8624892D0 (en) | Assay method | |
GB8724461D0 (en) | Assay method | |
GB8727822D0 (en) | Assay method | |
GB8724460D0 (en) | Assay method | |
GB8717540D0 (en) | Assay techniques & apparatus | |
GB8824493D0 (en) | Assay method | |
GB8824490D0 (en) | Assay method | |
GB8619113D0 (en) | Assay techniques | |
GB8909106D0 (en) | Assay method |